Answer
Vorasidenib should not be used during pregnancy because it can cause fetal harm, animal studies have shown embryo-foetal developmental toxicity, and data in pregnant women are limited.
Sources for this answer
- Voranigo 10 mg film-coated tabletServier Laboratories Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked